" class="no-js "lang="en-US"> Companies Archive - Page 3 of 145 - Medtech Alert
Wednesday, September 10, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Eisai | MTA

Eisai

View Company

 Maze Therapeutics | MTA

Maze Therapeutics

View Company

 GC Biopharma | MTA

GC Biopharma

View Company

 AlloVir | MTA

AlloVir

View Company

 Aptar | MTA

Aptar

View Company

 AST | MTA

AST

View Company

 MCRA | MTA

MCRA

View Company

 B dot Medical | MTA

B dot Medical

View Company

 Phio Pharmaceuticals | MTA

Phio Pharmaceuticals

View Company

 Prokarium | MTA

Prokarium

Load More Results